Received Feb 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | N/A | 255T2 | IM / LA |
Patient had previously received this same vaccine on 12/22/2023. Reporting this event as per the guidelines it is not recommended to receive a second dose of the RSV at this time. No adverse reactions were reported by that patient from the vaccine.